Acumen Historical Financial Ratios
| ABOS Stock | USD 1.32 0.02 1.49% |
Acumen Pharmaceuticals is presently reporting on over 90 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 0.66 or Days Sales Outstanding of 13.66 will help investors to properly organize and evaluate Acumen Pharmaceuticals financial condition quickly.
Acumen |
About Acumen Financial Ratios Analysis
Acumen PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Acumen Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Acumen financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Acumen Pharmaceuticals history.
Acumen Pharmaceuticals Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Acumen Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Acumen Pharmaceuticals sales, a figure that is much harder to manipulate than other Acumen Pharmaceuticals multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Most ratios from Acumen Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Acumen Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acumen Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Acumen Stock please use our How to Invest in Acumen Pharmaceuticals guide.At this time, Acumen Pharmaceuticals' Ebt Per Ebit is comparatively stable compared to the past year. Effective Tax Rate is likely to gain to 0.07 in 2025, whereas Operating Cash Flow Per Share is likely to drop (1.07) in 2025.
| 2024 | 2025 (projected) | Graham Number | 10.41 | 7.68 | Receivables Turnover | 15.15 | 14.39 |
Acumen Pharmaceuticals fundamentals Correlations
Click cells to compare fundamentals
Acumen Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Acumen Pharmaceuticals fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | (43.41) | 1.22 | 1.16 | 0.7 | 0.63 | 0.66 | |
| Book Value Per Share | (0.46) | 5.56 | 4.65 | 5.51 | 4.96 | 5.2 | |
| Free Cash Flow Yield | (0.009231) | (0.0658) | (0.16) | (0.23) | (0.27) | (0.25) | |
| Operating Cash Flow Per Share | (0.19) | (0.44) | (0.87) | (0.89) | (1.02) | (1.07) | |
| Pb Ratio | (43.41) | 1.22 | 1.16 | 0.7 | 0.63 | 0.66 | |
| Free Cash Flow Per Share | (0.19) | (0.44) | (0.87) | (0.89) | (1.02) | (1.07) | |
| Roic | (0.21) | 0.49 | (0.23) | (0.2) | (0.18) | (0.19) | |
| Net Income Per Share | (0.18) | (4.49) | (1.0) | (1.08) | (1.24) | (1.3) | |
| Payables Turnover | 0.0151 | 0.003676 | 0.1 | 30.69 | 27.62 | 29.0 | |
| Cash Per Share | 1.09 | 4.8 | 4.37 | 5.02 | 4.52 | 2.47 | |
| Pocfratio | (108.33) | (15.23) | (6.24) | (4.32) | (3.89) | (4.09) | |
| Pfcf Ratio | (108.33) | (15.2) | (6.21) | (4.32) | (3.89) | (4.08) | |
| Ev To Operating Cash Flow | (102.45) | (8.43) | (2.54) | (3.43) | (3.09) | (3.24) | |
| Pe Ratio | (110.19) | (1.51) | (5.42) | (3.56) | (3.2) | (3.36) | |
| Ev To Free Cash Flow | (102.45) | (8.41) | (2.53) | (3.43) | (3.09) | (3.24) | |
| Earnings Yield | (0.009075) | (0.66) | (0.18) | (0.28) | (0.32) | (0.34) | |
| Net Debt To E B I T D A | (74.58) | (1.98) | 3.05 | 0.74 | 0.67 | 0.7 | |
| Current Ratio | 6.98 | 38.6 | 23.08 | 19.01 | 17.11 | 14.88 | |
| Tangible Book Value Per Share | (0.46) | 5.56 | 4.65 | 5.51 | 4.96 | 5.2 | |
| Graham Number | 1.38 | 23.71 | 10.21 | 11.57 | 10.41 | 7.68 | |
| Shareholders Equity Per Share | (0.46) | 5.56 | 4.65 | 5.51 | 4.96 | 5.2 | |
| Graham Net Net | (0.48) | 4.67 | 4.18 | 4.14 | 3.72 | 1.95 | |
| Enterprise Value Over E B I T D A | 1.3K | 2.46 | (2.09) | (2.86) | (3.29) | (3.13) | |
| Price Earnings Ratio | (110.19) | (1.51) | (5.42) | (3.56) | (3.2) | (3.36) | |
| Price Book Value Ratio | (43.41) | 1.22 | 1.16 | 0.7 | 0.63 | 0.66 | |
| Price To Operating Cash Flows Ratio | (108.33) | (15.23) | (6.24) | (4.32) | (3.89) | (4.09) | |
| Price To Free Cash Flows Ratio | (108.33) | (15.2) | (6.21) | (4.32) | (3.89) | (4.08) | |
| Ebt Per Ebit | 0.93 | (1.63) | 0.95 | 0.86 | 0.99 | 1.03 | |
| Company Equity Multiplier | (2.39) | 1.02 | 1.04 | 1.16 | 1.05 | 1.1 | |
| Quick Ratio | 6.98 | 38.6 | 23.08 | 19.01 | 17.11 | 14.88 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.